AFP is the only serum biomarker that has widely been used in the diagnosis of HCC[11]; GPC3 is also a potential reliable biomarker and therapeutic target in HCC[12]; PGC is overexpressed in HCC[13]; AKR1B10 is a valuable novel biomarker candidate for staging of HCC[14]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.